Home / FAQ / Pharmacy / How Is My Pharmacy Reimbursed by the NHS?  

How Is My Pharmacy Reimbursed by the NHS?  

The process by which a pharmacy in England and Wales is reimbursed by the NHS is governed by the Community Pharmacy Contractual Framework (CPCF), which combines two distinct financial elements: Reimbursement (to cover drug costs) and Remuneration (to cover professional fees). The primary document detailing this complex monthly payment breakdown is the Schedule of Payments (FP34), issued by the NHS Business Services Authority (NHSBSA), which provides the critical data needed for the pharmacy’s bookkeeping and tax compliance with HMRC.

Dual Components of NHS Pharmacy Funding

NHS Pharmacy Funding, often referred to collectively as the Global Sum, is structured to ensure fair compensation for both the physical product and the professional service provided.

Component 1: Reimbursement (Covering Drug Costs)

Reimbursement is the money the NHS pays to the pharmacy to cover the acquisition cost of the prescribed drugs and appliances. The primary reference document for these prices is the Drug Tariff.

The Drug Tariff and Category M Pricing

What is the Drug Tariff and how does it determine the reimbursement price? The Drug Tariff is a complex, comprehensive document updated monthly by the NHSBSA. It dictates the maximum price the NHS will pay the pharmacy for each dispensed item.

  • Category M Pricing: This is the key reimbursement mechanism for a large volume of generic medicines. Category M prices are set quarterly by the DHSC using market data and are intentionally set above the average market purchase price. This deliberate differential creates the Retained Margin (RM), which is the purchase profit a pharmacy can earn by sourcing drugs below the set Tariff price.
  • Clawback: The Retained Margin component of the overall Global Sum is constantly monitored. If pharmacies collectively earn too much margin, the DHSC applies a Clawback mechanism, adjusting the Category M prices downwards in future months to recoup the “over-delivery.”

Component 2: Remuneration (Fees and Allowances)

Remuneration is the payment made to the pharmacy for its professional services, time, and expenses.

What is the difference between Remuneration and Reimbursement in the CPCF?

  • Remuneration (Fees): This is the pharmacy’s earned income for professional services (e.g., dispensing, clinical checks, advanced services). This is money the pharmacy keeps as true revenue.
  • Reimbursement (Drug Costs): This is intended only to cover the pharmacy’s Cost of Goods Sold (COGS).
  • The core of Remuneration is the Single Activity Fee (SAF). The SAF is paid for each item dispensed and replaces a collection of older separate fees (dispensing, practice, and repeat dispensing fees). Other forms of Remuneration include payments for Advanced Services (e.g., New Medicine Service – NMS, Pharmacy First), quality schemes, and establishment payments.

Monthly Reconciliation and Tax Reporting

The entire funding process is tracked monthly through a centralised system that culminates in a mandatory financial document for the contractor.

The Schedule of Payments (FP34)

The Schedule of Payments (FP34) is the essential monthly statement provided by the NHSBSA. It summarises all financial transactions for the previous month’s dispensed prescriptions.

  • Contents: The FP34 details the total gross reimbursement value (for drugs), the professional fees and allowances (Remuneration), the deduction for patient prescription charges collected, and any necessary adjustments (such as the estimated Clawback of Retained Margin).
  • Payment Cycle: Pharmacies submit their prescription bundle and the FP34C claim form (often digitally via the Manage Your Service – MYS – portal) to the NHSBSA. The NHS typically makes an Advance Payment (an estimate based on previous claims) shortly after submission, with the final, reconciled payment arriving around two months later, based on the actual priced prescriptions.

HMRC Taxable Profits Assurance

All income streams must be correctly classified to calculate Taxable Profits for HMRC.

How does HMRC treat the funding received via the Single Activity Fee for taxation?

The Single Activity Fee (SAF) is treated as Taxable Revenue in full.

  • Remuneration (Fees): All fees and allowances (SAF, NMS payments) are direct revenue and are fully subject to Corporation Tax (CT) (for limited companies) or Income Tax (IT) (for sole traders/partners) after the deduction of Allowable Expenses.
  • Reimbursement (RM): The profit generated by the Retained Margin is also treated as trading income. The key is that the full NHS reimbursement amount is offset by the actual drug purchase price (COGS), leaving the RM component as the Gross Profit. This Gross Profit contributes to the Taxable Profits reported on the company’s CT600 or the proprietor’s Self Assessment (SA) Tax Return.

AZL: Mastering Your NHS Funding Reconciliation and Profitability

Navigating the CPCF particularly the complex reconciliation of the FP34 and the fluctuating Retained Margin is highly specialised. AZL provides expert Chartered Accountants in England & Wales to ensure optimal funding and full tax compliance for the pharmacy sector.

Schedule of Payments (FP34) Reconciliation

We guarantee financial accuracy by reconciling NHS statements with your bookkeeping.

Forensic Reconciliation: AZL conducts a precise, item-by-item reconciliation of the monthly Schedule of Payments (FP34) against the pharmacy’s bookkeeping records. We verify that all fees and reimbursement amounts are correct according to the Drug Tariff, identifying discrepancies that can often result in under-claiming.

Margin Optimisation and Clawback Forecasting

We manage volatility by optimising buying practices against the NHS pricing model.

  • RM Analysis: We provide ongoing analysis of purchasing efficiency against Category M Pricing to maximise the Retained Margin (RM).
  • Clawback Risk Management: AZL forecasts the likely impact of the national Clawback mechanism on the pharmacy’s cash flow, enabling the business to maintain necessary Working Capital and avoid financial distress.

HMRC Taxable Profits Assurance

We ensure compliant categorisation that minimises HMRC scrutiny.

Taxable Profits Classification: AZL ensures every NHS payment is correctly classified in the bookkeeping as either Taxable Remuneration or COGS recovery. This is vital for accurate final calculation of Taxable Profits for CT or IT reporting.

Integrated Compliance Assurance

Our specialised service provides financial resilience and stability.

  • Bookkeeping Integrity: Our bookkeeping is specifically structured for pharmaceutical funding, providing the robust data necessary for statutory accounts and tax returns.
  • Payroll Cost Management: By maximising NHS funding flows, we ensure the pharmacy maintains stable revenue to cover fixed operating costs, such as Payroll.
  • Inheritance Tax Planning: A well-managed and optimised NHS funding stream provides verifiable profitability, supporting a stable, high business valuation for Inheritance Tax planning.
Secret Link